🚀 VC round data is live in beta, check it out!
Chordate Medical Holding Valuation Multiples
Discover revenue and EBITDA valuation multiples for Chordate Medical Holding and similar public comparables like Remedent, EvokAI, Epigenomics, Inhalation Sciences SWE and more.
Chordate Medical Holding Overview
About Chordate Medical Holding
Chordate Medical Holding AB is a medical technology company that has developed patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel, and Saudi Arabia. The company’s product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.
Founded
2005
HQ
Employees
3
Website
Sectors
Financials (FY)
Market Cap
$64K
Chordate Medical Holding Stock Performance
Chordate Medical Holding has current market cap of $64K.
Market Cap Evolution
Chordate Medical Holding's stock price is $0.02.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $64K | 0.4% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChordate Medical Holding Valuation Multiples
Chordate Medical Holding Financial Valuation Multiples
As of April 8, 2026, Chordate Medical Holding has market cap of $64K.
Equity research analysts estimate Chordate Medical Holding's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $64K | XXX | $64K | XXX | XXX | XXX |
| EV (current) | ($393K) | XXX | ($393K) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Chordate Medical Holding Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Chordate Medical Holding Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Remedent | XXX | XXX | XXX | XXX | XXX | XXX |
| EvokAI | XXX | XXX | XXX | XXX | XXX | XXX |
| Epigenomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Inhalation Sciences SWE | XXX | XXX | XXX | XXX | XXX | XXX |
| Nuwellis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chordate Medical Holding M&A Activity
Chordate Medical Holding acquired XXX companies to date.
Last acquisition by Chordate Medical Holding was on XXXXXXXX, XXXXX. Chordate Medical Holding acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Chordate Medical Holding
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialChordate Medical Holding Investment Activity
Chordate Medical Holding invested in XXX companies to date.
Chordate Medical Holding made its latest investment on XXXXXXXX, XXXXX. Chordate Medical Holding invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Chordate Medical Holding
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Chordate Medical Holding
| When was Chordate Medical Holding founded? | Chordate Medical Holding was founded in 2005. |
| Where is Chordate Medical Holding headquartered? | Chordate Medical Holding is headquartered in Sweden. |
| How many employees does Chordate Medical Holding have? | As of today, Chordate Medical Holding has over 3 employees. |
| Is Chordate Medical Holding publicly listed? | Yes, Chordate Medical Holding is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Chordate Medical Holding? | Chordate Medical Holding trades under CMH ticker. |
| When did Chordate Medical Holding go public? | Chordate Medical Holding went public in 2022. |
| Who are competitors of Chordate Medical Holding? | Chordate Medical Holding main competitors are Remedent, EvokAI, Epigenomics, Inhalation Sciences SWE. |
| What is the current market cap of Chordate Medical Holding? | Chordate Medical Holding's current market cap is $64K. |
| Is Chordate Medical Holding profitable? | No, Chordate Medical Holding is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.